Combination Of Amg 160, A Psma X Cd3 Half-Life Extended Bispecific T-Cell Engager (Hle Bite) Immune Therapy, With An Anti-Pd-1 Antibody In Prostate Cancer (Pca)

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 5|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要